We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allied Health | LSE:AHI | London | Ordinary Share | COM STK USD0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 120.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAHI RNS Number : 8164W Allied Healthcare International Inc 04 August 2009 Revenues Increase 7.3%, at Constant Exchange Rates NEW YORK, NY--(Marketwire - August 04, 2009) - Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI) Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI) (http://www.alliedhealthcare.com), a leading provider of flexible healthcare staffing services in the United Kingdom, has issued financial results for its fiscal 2009 third quarter. To provide investors with an increased understanding of the Company's business, as in previous quarters, Allied is providing a breakdown of its revenues, gross profits, selling, general and administrative costs and operating income at constant exchange rates using the comparable prior period weighted average exchange rate. In addition, as the Company's revenues and gross profits are generated in the United Kingdom, an analysis is included, within the management discussion below, of the last seven quarters' revenues and gross profits in pounds sterling to enable investors to fully understand the underlying trends over these periods without the effects of currency exchange rates. As noted in the reported numbers, recent fluctuations in foreign exchange rates have significantly impacted the Company's current period results. Fiscal Third Quarter Results: For the third quarter of fiscal 2009, at constant exchange rates, revenues increased by $5.5 million, or 7.3%, to $80.5 million, compared with $75.0 million reported during the same period in fiscal 2008. Contributing to the increase in revenues was Allied's Homecare revenues, which grew by 17.3% to $67.5 million. Nursing Home revenues declined by 25.3% to $7.3 million. Hospital revenues decreased by 26.0% to $5.7 million. After the unfavorable impact of currency exchange of $17.4 million, revenues decreased to $63.1 million. At constant exchange rates, total gross profit for the third fiscal quarter increased 5.8% to $24.5 million, compared with $23.1 million reported for the comparable quarter in fiscal 2008. Gross profit margin for the third quarter was 30.4%, as compared to 30.8% for the comparable prior period. Foreign exchange decreased gross profit by $5.3 million to $19.2 million for the quarter. At constant exchange rates, SG&A for the third fiscal quarter was $20.5 million, compared with $19.4 million reported last year. As a percent of revenues, SG&A costs were 25.8%, compared to 25.9% in the comparable prior year period. Foreign exchange decreased costs by $4.2 million to $16.3 million for the quarter. At constant exchange rates, operating income for the third quarter of fiscal 2009 increased to $4.0 million, compared to operating income of $3.7 million reported during the 2008 third fiscal quarter. Foreign exchange decreased operating income by $1.1 million to $2.9 million for the quarter. Net income for the third quarter of fiscal 2009 was $2.4 million, as compared with $2.5 million reported during the 2008 third fiscal quarter. Diluted earnings per share was $0.05 for the quarter, compared to diluted earnings per share of $0.05 last year. Fiscal Nine-Month Results: For the fiscal nine months ended June 30, 2009, at constant exchange rates, revenues increased by $12.8 million, or 5.7%, to $236.4 million, compared with $223.6 million reported during the same period in fiscal 2008. Contributing to the increase in revenues was Allied's Homecare revenues, which grew by 13.8% to $191.2 million. Nursing Home revenues declined by 21.1% to $25.3 million. Hospital revenues decreased by 15.2% to $19.9 million. After the unfavorable impact of currency exchange of $56.4 million, revenues decreased to $180.0 million. At constant exchange rates, total gross profit for the fiscal nine months ended June 30, 2009, increased 7.4% to $72.5 million, compared with $67.5 million reported for the comparable period in fiscal 2008. Gross profit margin for the fiscal nine months ended June 30, 2009, increased to 30.6% from 30.2% for the comparable prior period. Foreign exchange decreased gross profit by $17.3 million to $55.2 million for the quarter. At constant exchange rates, SG&A for the fiscal nine months ended June 30, 2009, was $60.0 million, compared with $59.1 million reported last year, an increase of 1.5%. As a percent of revenues, SG&A costs were 25.7% compared to 26.4% in the comparable prior year period. Foreign exchange decreased costs by $13.8 million to $46.2 million for the quarter. At constant exchange rates, operating income for the fiscal nine months ended June 30, 2009, increased to $12.5 million, compared to operating income of $8.4 million reported during the 2008 nine months ended June 30, an increase of 48.6% over the prior year. Foreign exchange decreased operating income by $3.5 million to $8.9 million for the nine-month period. Income from continuing operations for the nine months ended June 30, 2009, increased to $7.0 million, as compared with $5.9 million reported during the 2008 fiscal nine-month period. Diluted earnings per share from continuing operations was $0.15 for the nine month period ended June 30, 2009, compared to diluted earnings per share from continuing operations of $0.13 last year. Net income for the nine months ended June 30, 2009, increased to $7.4 million, as compared with $5.9 million reported during the 2008 fiscal nine-month period. Diluted earnings per share was $0.16 for the nine-month period, which includes $0.01 from discontinued operations due to the release of reserves as a result of the warranty period within the sales agreement, related to the sale of the respiratory business in fiscal 2007, having expired. This compares to $0.13 for the same prior year period. At June 30, 2009, and September 30, 2008, Allied's cash balance was $33.7 million (GBP20.4 million) and $26.2 million (GBP14.4 million), respectively, representing an underlying increase in the cash balance of GBP6.0 million. For the fiscal nine months ended June 30, 2009, depreciation and amortization was $2.8 million (GBP1.8 million) and capital expenditures were $2.2 million (GBP1.4 million). Days Sales Outstanding was twenty-four days at June 30, 2009 (46 days including unbilled account receivables), and twenty-five days at June 30, 2008 (44 days including unbilled account receivables). Management Discussion: "We continue to see good growth in our homecare business, which now represents almost 84% of our business," commented Sandy Young, Chief Executive Officer of Allied. "The revenue growth in the quarter of 17.3% was particularly pleasing and was ahead of the 10-15% growth range that we have recently been operating within. Our Continuing Care continues to grow strongly and accounts for over 15% of the revenues of this business. Continuing Care has benefitted from the restructuring we carried out earlier this year. We have low penetration in this market and our proposition of providing homecare with a lower level medical requirement via support staff under nurse supervision is popular with hospital trusts." Mr. Young continued: "Our nursing homes and hospital staffing business results continue to struggle but following our acceptance onto the new PASA framework agreements, which come into effect in October 2009, we are hopeful that the higher charges under this revised contract will give us opportunities going forward. The higher charges are necessary to enable us to effectively recruit staff to service this business. We currently have plans in the next financial year to re-launch this service line in a few of our regional offices as well as our existing London operation. "While current period SG&A running costs of 25.8% of revenues are lower than the prior year period, we are continuing to invest in certain areas of our business that includes such items as continuing care, learning disability, IT systems, and business improvement projects to ensure that we support future growth in revenues. At the same time, we maintain tight controls over other areas of SG&A costs so as to maintain our objective of reducing SG&A costs as a percent of revenues. "We currently have several business improvement initiatives under way with project management support. These projects cover winning new business, carer retention, bid implementation, and branch operations. There are also other projects supporting service delivery. We believe that being a high quality service provider is a key driver to increased revenue and profit growth. "The third quarter also concluded the successful pilot phase of our Coldharbour IT replacement. We now have thirteen branches successfully running on Coldharbour. The cost of the project is within the original budget and time projections with a total capital expenditure of $2.4 million and operating expense of $4.5 million. To date, expenditures have been $2.7 million split between $2.2 million capital and $0.5 million operating expense. The project will allow us to make further efficiencies in the way we process transactions and will also improve service delivery." Mr. Young concluded: "As noted in our previous quarter's press release, with nearly all our operations in the United Kingdom, we believe it is important for investors to see the underlying revenues and gross profits in pound currency as detailed below. This shows growth in our gross margins year to date of 7.4% and our third quarter gross margin of 30.4% is well within our expectations. Our SG&A costs year to date, excluding exchange effects, increased by 1.5%, compared to the prior year despite the increase in revenues that we have generated." Dr. Jeffrey Peris, Non-Executive Chairman of the Board of Allied, commented: "Sandy Young and the management team have achieved operating income for the first three quarters of $12.5 million, excluding exchange, which compares to $8.4 million for the same prior year's quarters. This is an increase of 48.6%, and reflects the continued improvements the Company is making across its business to help it affirm its position as one of the leaders in the U.K. homecare market place. We are pleased with the results of the third quarter and that the successes of previous quarters have enabled Allied to be included in the Russell 3,000 Index, thereby providing us with opportunities to reach additional investors." Conference Call Information -- August 4, 2009 at 10:00AM EST / 3:00PM GMT: Allied invites all those interested in listening to management's discussion of the results to join the call by dialing 877-407-0778 for domestic participants, and 201-689-8565 for international participants today, August 4, 2009, at 10:00AM EST / 3:00PM GMT. Participants may also access a live webcast of the conference call through the "Investors" section of Allied Healthcare's Website: www.alliedhealthcare.com. A replay will be available for one week following the call by dialing 877-660-6853 for domestic participants, and 201-612-7415 for international participants. When prompted, please enter account number 286 and conference ID number 321299. The presentation will be available and archived on the Company's website for ninety days. In addition to disclosing results of operations that are determined in accordance with generally accepted accounting principles ("GAAP"), this press release also discloses non-GAAP results of operations that exclude or include certain charges. These non-GAAP measures adjust for foreign exchange effects. Management believes that the presentation of these non-GAAP measures provides useful information to investors regarding the Company's results of operations, as these non-GAAP measures allow investors to better evaluate ongoing business performance. Investors should consider non-GAAP measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. A reconciliation of the non-GAAP measures disclosed in this press release with the most comparable GAAP measures are included in the financial tables included in this press release. For more news and information on Allied Healthcare International Inc., please visit http://www.IRGnews.com/coi/AHCI where you can find the CEO's video, a fact sheet on the company, investor presentations, and more. ABOUT ALLIED HEALTHCARE INTERNATIONAL INC. Allied Healthcare International Inc. (http://www.alliedhealthcare.com) is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of approximately one hundred ten branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of private patients, community care, nursing and care homes, and hospitals. FORWARD-LOOKING STATEMENTS Certain statements contained in this news release may be forward-looking statements. These forward-looking statements are based on current expectations and projections about future events. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements include: general economic and market conditions; Allied's ability to continue to recruit and retain flexible healthcare staff; Allied's ability to enter into contracts with local government social services departments, NHS Trusts, hospitals and other healthcare facility clients on terms attractive to Allied; the general level of patient occupancy at our clients' hospitals and healthcare facilities; dependence on the proper functioning of Allied's information systems; the effect of existing or future government regulation of the healthcare industry, and Allied's ability to comply with these regulations; the impact of medical malpractice and other claims asserted against Allied; the effect of regulatory change that may apply to Allied and that may increase costs and reduce revenues and profitability; Allied's ability to use net operating loss carry forwards to offset net income; the effect that fluctuations in foreign currency exchange rates may have on our dollar-denominated results of operations; and the impairment of goodwill, of which Allied has a substantial amount on the balance sheet, may have the effect of decreasing earnings or increasing losses. Other factors that could cause actual results to differ from those implied by the forward-looking statements in this press release include those described in Allied's most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. Allied undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Contacts: Allied Healthcare International Inc. Sandy Young Chief Executive Officer Paul Weston Chief Financial Officer UK 00-44-1785 810-600 sandyyoung@alliedhealthcare.com paulweston@alliedhealthcare.com or The Investor Relations Group Adam Holdsworth 212-825-3210 or Cenkos Securities plc (Nominated Advisor) Elizabeth Bowman London: 00-44-20-7397-8928 or Ian Soanes London: 00-44-20-7397-8924 This information is provided by RNS The company news service from the London Stock Exchange END QRTSSFSLLSUSEDA
1 Year Allied Healthcare Chart |
1 Month Allied Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions